Skip to content
Disclosery

BB BIOTECH AG

Follow

13F filer, CIK 924223, SCHAFFHAUSEN, Switzerland

BB BIOTECH AG filed a 13F-NT notice for the quarter ended 2026-06-30 on 2026-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-NT 0001104659-26-096749

This filer reports no holdings of its own for Q2 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.

Changes against Q1 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.

Part of the filer group Bellevue Group AG

How groups are built

Stakes and trades reported after 2026-06-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • YARW YARROW BIOSCIENCE INC: 13G 1,000,000 shares, 10.6% of the class, 13G filed 2026-10-07, 0001104659-26-114282Timeline
    Accepted , ingested

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-NT 0001104659-26-096749 notice2026-08-14acceptance time not in the bulk data set